Although further research is needed, our pre-clinical data showed that G-CSF promotes tumor growth in the CPA-induced neutropenia EL4 tumor-bearing model, which would result from the enhancement of immunosuppressive function and the increase in the number of MDSCs by G-CSF. This evidence concerns the gene CSF3 and neutropenia.